🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A challenging question I've been asking myself over and over since I encountered my first BTD patient 8 years ago. Honored to help try to answer it here and learn from our counterpoint authors.

A ton of fun. Thanks to Dr. Pradhan and ATS Scholar for the opportunity!

Dr. Niall Ferguson Ricardo Teijeiro Paradis Toronto Western Hospital Critical Care UHN Research Intensive Care Medicine More to come #ECMO liberation from Ricardo Teijeiro Paradis and in collaboration with Whitney Gannon Todd Rice Jon Casey from @VUMC_ECMO International ECMO Network (ECMONet)

Great work, Eddy and colleagues. Can't wait to get our collaboration rolling and see how we change ECMO weaning and liberation together.

When to discontinue VV #ECMO still unclear... Which parameters predict successful liberation?? Which associated with safe/unsafe weaning? 📖 CHEST Editorial bit.ly/3bUC8cn Refers to 📖 Whitney Gannon bit.ly/3qjAgm5 📖 Abdulrahman Al-Fares bit.ly/3kkun44

Providing ECMO to COVID patients is hard. These young patients stay sick for a really long time . . . and some die despite ECMO. It can leave you wondering how much benefit ECMO for COVID. The answer is a lot: atsjournals.org/doi/abs/10.116…

Must-read new evidence on the effect of ECMO during COVID using periods of research limitations as a natural experiment. Congratulations to Whitney Gannon and ATS Early Career Mentoring Program Chair Jon Casey for this important work: atsjournals.org/doi/abs/10.116…

Bleeding & thrombosis in severe #COVID19 pts on #ECMO: need for harmonization of hemostasis management across centers & for evaluating anticoagulation strategies highlighted by ECMOSARS registry 🇫🇷 nationwide cohort 📎 bit.ly/3yBzGmi Editorial 📎 bit.ly/3yEeagt

Same.

Learned a ton working on this with Ricardo Teijeiro Paradis and Eddy Fan. Important consideration of the downsides across the spectrum of ECMO care.

NEJM Evidence Laveena Munshi Toronto Western Hospital Critical Care University of Toronto Temerty Medicine IHPME Columbia Critical Care Medicine Columbia Vagelos College of Physicians & Surgeons NewYork-Presbyterian Join us on Wed Oct 19 at #CHEST2022 where we will discuss related topics in “What’s New in Extracorporeal Support” with Whitney Gannon #AdanMora #BrandyMcKelvy

When you get to hang out with a couple of good people who both make you laugh and teach you things... well, that's pretty much the best. Thank you for having me ICUEdandToddCast

Research & #ECMO?? Eddy Fan #ELSO2023 📉Feasibility major challenge for #ECLS RCT... Do NOT only rely on these: lot of unknowns, lot of questions to answer in the field of #ECMO #ECLS... RCTs would not be able to answer all of these questions: using observational data to emulate

🩸 The road of lower intensity anticoagulation in #ECMO might reduce bleeding complications improving outcome in #ARDS patients. Personalized approach should consider underlying disease process & its distinct pathophysiology in determining optimal dose and target ranges of

VERY honored to be back on the ICUEdandToddCast with Eddy Fan for some discussion around clinical trials in ECMO and lessons learned from important trials like this one!

Whitney Gannon ICUEdandToddCast Great discussion with Whitney Gannon with some great hosts! Thanks again for the invite. International ECMO Network (ECMONet) ELSO

LIVE learning and laughing with ICUEdandToddCast at #CCBootcamp2024 ! Edward Qian Todd Rice fantastic kickoff to my favorite place to learn every year! Sarah Bloom

If you ❤️ 🫁, 🫀, transplant, ECMO, & Nashville 🤠, join Vandy, the busiest 🫀&🫁 transplant program in the world & ⭐️ ECMO program. W/ a joint affiliation w/ LOR3, you will participate in cutting edge artificial 🫁 and 🫀failure large animal studies. DM me or email. @VUMC_ECMO

Low vs moderate-intensity anticoagulation for VV #ECMO 🔍 SAFE-ECMO pilot trial; 3 centers across 🇺🇸 💉 intermittent SC anticoagulant (doses for DVT prophylaxis) vs traditional approach to anticoagulation with continuous, goal-titrated, infusion 🩸major bleedings 8.3% in low vs

Important ?? in the care of pts on VV-ECMO. We worry about clotting the circuit/oxygenator, but multiple studies have now shown pts have more morbidity/mortality from bleeding than clotting. Maybe with newer technology, etc, the need for systemic anticoagulation isn't needed?